Bayer Buys License For ISIS Pharma's Ant-clotting Drug ISIS-FXIRx By: TalkMarkets May 04, 2015 at 15:24 PM EDT Shares of ISIS Pharmaceuticals are up 5% on the news of Bayer AG licensing its anti-clotting drug. Read More >> Related Stocks: Bayer Aktienges ADR